Transgenic overexpression of GLUT4, either under the control of the native promoter or a tissue-specific, heterologous promoter, led to enhanced insulin sensitivity, enhanced glucose clearance, and provides some protection against insulin resistance. This evidence concerns the gene INS and Insulin resistance.